| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
COVID-19 and gastroenteric manifestations
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zhang-Ren Chen, Jing Liu, Zhi-Guo Liao, Jian Zhou, Hong-Wei Peng, Fei Gong, Jin-Fang Hu and Ying Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81903724 |
| Natural Science Foundation of Jiangxi Province |
20181BBG70008 |
|
| Corresponding Author |
Ying Zhou, PhD, Associate Chief Pharmacist, Research Assistant Professor, Research Scientist, Department of Pharmacy, The First Affiliated Hospital of Nanchang University, No. 17 Yongwaizhengjie, Donghu District, Nanchang 330100, Jiangxi Province, China. zyyiva@163.com |
| Key Words |
COVID-19; SARS-CoV-2; Gastroenteric manifestations; Adverse drug reaction; Management |
| Core Tip |
Gastroenteric manifestations, including anorexia, nausea, vomiting, diarrhea, abdominal pain, and gastrointestinal bleeding, can worsen the situation of patients with coronavirus disease 2019 (COVID-19). More efforts should be spared to understand its pathology and mechanism. Besides the infection of severe acute respiratory syndrome coronavirus 2 virus, the treatments of COVID-19 also contribute to the gastroenteric manifestations due to the adverse drug reactions (ADRs) of anti-COVID-19 drugs. Timely supportive or symptomatic treatment and withdrawal of ADRs-inducing drugs can do help to manage COVID-19-associated gastroenteric manifestations. |
| Publish Date |
2021-06-24 07:26 |
| Citation |
Chen ZR, Liu J, Liao ZG, Zhou J, Peng HW, Gong F, Hu JF, Zhou Y. COVID-19 and gastroenteric manifestations. World J Clin Cases 2021; 9(19): 4990-4997 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i19/4990.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i19.4990 |
